Skip to main content
Account

Peer review reports

From: Integration of clinical and blood parameters in risk prognostication for patients receiving immunochemotherapy for extensive stage small cell lung cancer: real-world data from two centers

Original Submission
1 Mar 2024 Submitted Original manuscript
10 Mar 2024 Reviewed Reviewer Report
24 Mar 2024 Reviewed Reviewer Report
25 Mar 2024 Reviewed Reviewer Report
16 Apr 2024 Author responded Author comments - Tongmei Zhang
18 May 2024 Reviewed Reviewer Report
27 May 2024 Reviewed Reviewer Report
1 Jul 2024 Author responded Author comments - Tongmei Zhang
Resubmission - Version 2
16 Apr 2024 Submitted Manuscript version 2
2 Jul 2024 Reviewed Reviewer Report
26 Jul 2024 Author responded Author comments - Tongmei Zhang
Resubmission - Version 3
26 Jul 2024 Submitted Manuscript version 3
28 Aug 2024 Author responded Author comments - Tongmei Zhang
Resubmission - Version 4
28 Aug 2024 Submitted Manuscript version 4
30 Aug 2024 Author responded Author comments - Tongmei Zhang
Resubmission - Version 5
30 Aug 2024 Submitted Manuscript version 5
3 Sep 2024 Author responded Author comments - Tongmei Zhang
Resubmission - Version 6
3 Sep 2024 Submitted Manuscript version 6
Publishing
4 Sep 2024 Editorially accepted
11 Sep 2024 Article published 10.1186/s12916-024-03612-8

Learn about peer review

Back to article page

Navigation